FDA Approves First New Sickle Cell Treatment in Decades
The FDA has announced its approval of Endari (L-glutamine oral powder) for the treatment of sickle cell disease, a hereditary blood disorder that can result in pain, organ damage, and shortened lifespan. Endari’s approval makes it the first drug approved for patients with the chronic illness in nearly 20 years, according to the FDA press release, and only the second drug on the market. It was developed by Emmaus Medical, Inc, with help from the FDA’s Orphan Products Grants Program and is designated as an Orphan Drug, meaning it is used to treat a rare disease.
Senate Health Bill Would Allow Psychiatric Facilities to Add More Beds
One of the components of the Senate’s proposed Better Care Reconciliation Act is designed to boost the number of available beds in psychiatric hospitals, Kaiser Health News reports. Traditionally, a CMS rule ensured that Medicaid will only pay for inpatient psychiatric stays in facilities with 16 beds or fewer, contributing to a shortage of beds. Instead, the Senate bill would provide federal matching Medicaid funds for inpatient psychiatric stays of up to 30 consecutive days or 90 days in a year, regardless of hospital size. According to aides, senators inserted the change in the healthcare bill out of concerns about mental health and addiction treatment access.
Nurse’s Drug Diversion Scheme Linked to Bacterial Outbreak
A nurse at the UW Health University Hospital in Madison, Wisconsin, is accused of tampering with syringes in order to obtain the narcotics in the syringes for illicit use or sale, also known as drug diversion. When she replaced the opioids with saline, it likely introduced a strain of bacteria that then caused an outbreak of Serratia marcescens among 5 patients infected by the syringes, according to Fierce Healthcare. The nurse was fired and the hospital has instituted stricter policies to prevent diversion, like tamper-evident packaging and more surveillance cameras.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More